Discover how new global guidelines aim to combat the rising threat of Candida infections with updated treatments and ...

The new guidelines provide updated diagnostic and therapeutic strategies for both mucocutaneous and invasive candidiasis.

Medically reviewed by Edmund Khoo, DDS Thrush, or oral candidiasis, is a fungal infection in your mouth and throat. It is ...

SCYNEXIS (NASDAQ:SCYX – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Thursday. SCYNEXIS Stock Up 8.6 % ...

The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in Q3 of 2025.Four presentations for SCY-247 were accepted ...

Investment analysts at HC Wainwright dropped their Q1 2025 earnings per share estimates for Cidara Therapeutics in a report ...

Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing ...

Abrocitinib was efficacious and safe in patients with atopic dermatitis who did and who did not respond to prior treatment with dupilumab.

The anti-inflammatory properties of probiotics found in DentPure are vital for promoting gum strength. By reducing ...

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...

Caress Flow, a pioneering innovation in women’s intimate health, made its UK debut at Vie Aesthetics in Holborn, marking the launch of its first flagship clinic. The exclusive event introduced press ...